Summary Using a panel of DNA probes for hypervariable DNA regions we screened 52 gastrointestinal carcinomas for clonal allele losses on chromosomes 1, 5, 7, 12, 16 and 17. A total of 24/35 informative cases of colorectal cancers showed loss of constitutional heterozygosity at a locus on chromosome 17p, while 9/31 cases informative for a locus on 5q showed allele loss. Loss of sequences at 5q was linked to allele loss at 17p with a single exception. In gastric cancers loss of heterozygosity most frequently occurred at lq (5/10 tumours) and at 12q (6/lltumours). Gastrointestinal tumours show consistent chromosomal losses and the loci involved are different in gastric and colorectal cancers.
Many human neoplasias show consistent chromosomal abnormalities (Yunis, 1983) . However, karyotyping of solid tumours has been hampered by technical problems of obtaining satisfactory mitoses. With the rapid increase in the numbers of mapped polymorphic DNA markers the molecular analysis of tumours has proved to be a powerful alternative approach for the detection of clonal allele losses in cancer DNA. This is exemplified by the inherited and sporadic forms of retinoblastoma (Cavenee et al., 1985) and other tumours (Ali et al., 1987; Brauch et al., 1987) . The search for regions of the human genome with consistent deletions in tumours appears to be a rational approach to the identification of tumour suppressor genes or anti-oncogenes (Knudson, 1985; Friend et al., 1988) .
Mutational activation of ras-oncogenes (Bos et al., 1987; Forrester et al., 1987) and somatic allele loss on the long arm of chromosome 5 (Solomon et al., 1987) , on the short arm of chromosome 17 and on chromosome 18 (Law et al., 1988) have been shown to be consistent genetic alterations in the development of colorectal cancers (Vogelstein et al., 1988) . However, previous reports on the molecular analysis of stomach cancers have been scarce (Motomura et al., 1988; Wada et al., 1988) and no comparison on the molecular analysis of non-random allele losses in these two groups of tumours has been reported.
Here we present a comparative molecular analysis of 52 gastrointestinal cancers by Southern blot hybridisation of constitutional and tumour DNA with a panel of highly polymorphic locus-specific DNA markers specific for particular chromosomal regions. The vast majority of individuals can be expected to be constitutionally heterozygous at these loci and, therefore, informative for analysis (Nakamura et al., 1987; Wong et al., 1987 (Maniatis et al., 1982) , digested with the appropriate restriction enzymes (Table I ) and the fragments separated by electrophoresis in 1% (w/v) agarose gels. The digests of tumour DNA were electrophoresed in tracks adjacent to digests of the corresponding constitutional DNA from blood and normal gastrointestinal mucosa. Fractionated DNA was transferred to nylon filters (Hybond-N, Amersham, UK) by Southern blotting and hybridised to DNA probes radiolabelled with 32P-deoxycytidine triphosphate by the random hexamer priming method (Feinberg & Vogelstein, 1983) . After hybridisation the filters were washed under stringent conditions and subjected to autoradiography between intensifier screens for one to four days at -70°C. Filters were hybridised with a different DNA probe after elution of the previous probe according to the manufacturer's instructions. DNA probes Digests of normal and tumour DNA from each case were hybridised consecutively to a panel of tandem repetitive DNA probes specific for hypervariable chromosomal regions (HVRs) (see Table I ).
Cases were considered informative for analysis at a given locus if the constitutional DNA showed heterozygosity, i.e. two detectable alleles. Tumour DNA was studied for loss of alleles present in the corresponding constitutional DNA. A phenomenon seen in Southern blot hybridisation using hypervariable DNA probes is that the shorter alleles tend to be less intense than the larger ones. This is related to the number of repeating units available for hybridisation in the shorter alleles. In view of this phenomenon, any intensity difference between two alleles in tumour DNA should be interpreted by comparison with the band patterns in constitutional DNA and the difference clearly discernable, as illustrated in Figures 2 and 3 . Furthermore, densitometer analysis to determine the ratios of hybridisation of alleles in the normal and tumour DNA would not be practical and it would be more realistic to correct for differences in DNA loading by rehybridising the filters with other nonhypervariable DNA probes, as carried out for the cases here. In all cases the loss of alleles became obvious on overexposure of the autoradiograph with respect to the other bands.
Statistical analysis was performed employing x2 tests in four-fold tables.
Results
Constitutional heterozygosity at the loci screened by our panel of HVR probes (ip, lq, 5q, 7p, 7q, 12q, 16p, 17p ) was present in 75-100% of the cases except for the a-globin 3' HVR probe which detected heterozygosity in only 46% of the cases (Table I) . In all the cases, the pattern of alleles detected by a particular probe in constitutional DNA from leukocytes was identical to that from the corresponding gastrointestinal mucosa. No allele loss or any other changes were observed in DNA from inflammatory lesions of the five cases of Crohn's disease, the six cases of breast cancer and the four colorectal adenomas.
Gastric cancers
The majority of the patients with gastric cancers were constitutionally heterozygous at seven of the nine loci Figure 1) . The most consistent somatic losses were observed at 1q (5 of 10 cases) detected by the probe pMUC1O and at 12q (6 of 11 cases) detected by the probe AMS43 (Table II, Figure 2) . Only a few cases of colorectal cancers showed somatic losses at these loci. The differences in the frequency of losses between gastric and the colorectal cancers at these loci is statistically significant (P<0.05 for pMUCl0; P<0.02 for AMS43). In contrast to the colorectal cancers, gastric tumours showed only occasional losses for sequences on 17p (2/10 informative cases) and on 5q (1/10 informative cases) (P <0.005).
Colorectal cancers Loss of heterozygosity was observed in tumour DNA in five of the six chromosomes examined (1, 5, 7, 12 and 17) with frequencies ranging from 3 to 69% of the informative cases (Table I and Figure 1 ). Twenty-four of the 35 tumours (69%) demonstrated a loss of one allele on the short arm of chromosome 17 as detected by the probe pYNZ22 ( Figure  3 ). This loss was significantly more frequent than losses observed with the other probes (P<0.02). Nine of 31 (29%) informative cases had a loss of heterozygosity on the long arm of chromosome 5 as detected by the probe 1MS8 (Figure 3 ). Twenty-six cases were informative for both pYNZ22 (17p) and AMS8 (5q); 13 demonstrated a loss of heterozygosity for 17p but were normal for 5q whereas nine demonstrated a loss of heterozygosity for 5q of which eight were accompanied by allele loss at 17p.
. Evidence is accumulating that malignant tumours may be generated by recessive mutations in somatic cells which are unmasked by a loss of the unaffected gene on the homologous chromosome (Harris, 1986 ). It appears that in various types of human cancers loss of heterozygosity consistently occurs at particular chromosomal loci. Previous cytogenetic studies of stomach carcinomas have demonstrated non-random losses of chromosomes 1, 7 and 12 (Ferti-Passantonopoulou et al., 1987; Sandberg, 1980) . Now using DNA probes we demonstrate at a molecular level that loss of alleles in stomach cancers is particularly frequent on chromosomes lq and 12q. Further studies, including a precise mapping of these loci, are warranted. We are aware of one other report on the study of allele loss in stomach cancers by a similar approach (Motomura et al., 1988 et al., 1988) . In this study, isolated losses were demonstrated at 25 loci on 18 different chromosomes; sequences on lq and 12q were not analysed.
The loss of sequences on chromosome lq detected by the probe pMUCIO is particularly interesting. pMUCIO detects a highly polymorphic locus coding for a family of mucintype glycoproteins abundant in normal epithelial tissues, body fluids and tumours of epithelial origin (Swallow et al., 1987a,b; Gendler et al., 1987) . It is the only hypervariable DNA locus in human DNA known to be transcribed and translated; moreover the expressed gene products show the same polymorphisms. While the present data are not sufficient to speculate as to how recessive mutations at this locus might influence the evolution of a malignant stomach tumour, the demonstration of clonal losses at a locus known to express tumour-associated antigens is certainly intriguing. Moreover, this chromosomal loss may be interstitial in some tumours; two gastric cancers (numbers 7 and 8, Table II ) demonstrate clonal loss with pMUC1O which is localised to lq2.1-2.4 but not with the probe AMS32 which is localised to lq4.2-4.3.
In colorectal cancer clonal loss of DNA sequences frequently and specifically occurs on chromosome 17p, as confirmed in this study, and on chromosome 18 (Law et al., 1988) . Since a substantial proportion of sporadic colorectal cancers also demonstrates allele losses at 5q22 (Solomon et al., 1987) , a region known to contain the gene for familial adenomatous polyposis (Bodmer et al., 1987) , it has been suggested that the loss of sequences at this locus may be a critical step in the evolution of colorectal tumours. Our data show that loss of heterozygosity at Sq rarely occurs as an isolated phenomenon in colorectal carcinomas, but rather in combination with losses on chromosome 17p, findings rather similar to those of Law et al. (1988) . In this study, it was found that of 31 colorectal cancers informative for chromosome 5 markers, six showed loss of heterozygosity at 5q with co-existing losses at chromosomes 17p and 18. As shown here and by others Okamoto et al., 1988) loss of heterozygosity in loci other than 18, 17p and 5q are only rarely involved in colonic cancers.
The precise localisation of the clonal allele losses to particular chromosomal regions will require further mapping studies which should be greatly helped by the increasing number of suitably mapped polymorphisms in the human genome (Donnis-Keller et al., 1987) . The construction of primary genetic maps for individual chromosomes should also help to determine if some of these losses involve all of one chromosome or were localised to specific regions of certain chromosomes. In addition to gene mapping, future studies should focus on .cloning the putative recessive oncogenes and anti-oncogenes involved in the development of malignant tumours as demonstrated in retinoblastoma (Friend et al., 1987) . Little is also known about the prognostic and epidemiological significance of these clonal chromosomal deletions. It has been demonstrated that nonrandom cytogenetic abnormalities may be of prognostic significance as best exemplified by the haematological neoplasms (Yunis et al., 1984) , and in certain solid tumours allelic deletions of c-rasHa and c-myc sequences have been shown to correlate with tumour progression and metastasis (Yokota et al., 1986) .
